Relationship of testis size and LH levels with incidence of major adverse cardiovascular events in older men with sexual dysfunction

Journal of Sexual Medicine

Volumn 10, Issue 11, 2013, Pages 2761-2773

  Rastrelli, Giulia ^a   Corona, Giovanni ^a,b   Lotti, Francesco ^a   Boddi, Valentina ^a   Mannucci, Edoardo ^c   Maggi, Mario ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b MAGGIORE HOSPITAL   (Italy)

^c UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Cardiovascular Events; Hypertension; Luteinizing Hormone; Testis Volume; Testosterone

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIURETIC AGENT; FOLLITROPIN; GONADOTROPIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; TESTOSTERONE; TRIACYLGLYCEROL;

ALCOHOL ABUSE; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; FOLLOW UP; GLAUCOMA; HOSPITALIZATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; HYPERURICEMIA; HYPOGONADISM; ISCHEMIC HEART DISEASE; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; MIGRAINE; OBESITY; PARKINSON DISEASE; PRIORITY JOURNAL; PULSE PRESSURE; RHEUMATOID ARTHRITIS; SEXUAL DYSFUNCTION; SMOKING; TESTICULAR ENLARGEMENT; TESTIS SIZE; TUBERCULOSIS;

CARDIOVASCULAR EVENTS; HYPERTENSION; LUTEINIZING HORMONE; TESTIS VOLUME; TESTOSTERONE;

AGE FACTORS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; HUMANS; INCIDENCE; ITALY; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TESTIS;

EID: 84887089857     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12270     Document Type: Article

References (51)

1. Behre HM, Nashan D, Nieschlag E. Objective measurement of testicular volume by ultrasonography: Evaluation of the technique and comparison with orchidometer estimates. Int J Androl 1989;12:395-403.
2. Prader A. Testicular size: Assessment and clinical importance. Triangle 1966;7:240-243.
3. Maggi M, Buvat J. Standard operating procedures: Pubertas tarda/delayed puberty-male. J Sex Med 2013;10:285-293.
4. Bhasin S, Basson R. Sexual dysfunction in men and women. In: Melmed S, Polonsky KS, Larsen PR, Kronenberg HM, eds. Williams textbook of endocrinology. 12th edition. Philadelphia, PA: Elsevier Saunders; 2011:793-795.
5. Sigman M, Jarow JP. Male infertility. In: Walsh PC, Retik AB, Darracot Vaughan E Jr, Wein AJ, eds. Campbell's urology. Vol. 2, 8th edition. Philadelphia, PA: Saunder Elsevier; 2002:1479.
6. Dohle GR. Clinical investigation on the infertile male. In: Bjorndahl L, Giwercman A, Tornaye H, Weidner W, eds. Clinical andrology. EAU/ESAU course guidelines. London: Informa Healthcare; 2010:9-17.
7. Forti G, Corona G, Maggi M. Clinical investigation and laboratory analyses in male hypogonadism. In: Bjorndahl L, Giwercman A, Tornaye H, Weidner W, eds. Clinical andrology. EAU/ESAU course guidelines. London: Informa Healthcare; 2010:245-259.
8. Behre HM, Yeung CH, Holstein AF, Weinbauer GF, Gassner P, Nieschlag E. Diagnosis of male infertility and hypogonadism. In: Nieschlag E, Behre H, eds. Andrology, male reproductive health and dysfunction. 2nd edition. Berlin: Springer; 1996.
9. Ghanem HM, Salonia A, Martin-Morales A. Standard operating procedures: Physical examination and laboratory testing for men with erectile dysfunction. J Sex Med 2013;10:108-110.
10. Hatzichristou D, Rosen R, Derogatis L, Meuleman E, O'Leary M, Vardi Y, Low WY, De Zava MS, Symonds T. Clinical evaluation and symptom scales: Sexual dysfunction assessment. In: Montorsi F, Basson R, Adaikan G, Becher E, Clayton A, Giuliano F, Khoury S, Sharlip I, eds. Sexual dysfunctions in men and women. Paris: Health Publication Ltd; 2010:229-280.
11. Kirby RS, Kirby MG. Basic assessment of the patient with erectile dysfunction. In: Carson CC, Kirby RS, Goldstein I, Wyllie MG, eds. Textbook of erectile dysfunction. 2nd edition. New York: Informa Healthcare; 2009:115-116.
12. Buvat J, Maggi M, Guay A, Torres LO. Testosterone deficiency in men: Systematic review and standard operating procedures for diagnosis and treatment. J Sex Med 2013;10:245-284.
13. Corona G, Mannucci E, Ricca V, Lotti F, Boddi V, Bandini E, Balercia G, Forti G, Maggi M. The age-related decline of testosterone is associated with different specific symptoms and signs in patients with sexual dysfunction. Int J Androl 2009;32:720-728.
14. Corona G, Rastrelli G, Forti G, Maggi M. Update in testosterone therapy for men. J Sex Med 2011;8:639-654.
15. Corona G, Rastrelli G, Vignozzi L, Mannucci E, Maggi M. How to recognize late onset hypogonadism in men with sexual dysfunction. Asian J Androl 2012;14:251-259.
16. Corona G, Mannucci E, Petrone L, Ricca V, Mansani R, Cilotti A, Balercia G, Chiarini V, Giommi R, Forti G, Maggi M. Psychobiological correlates of smoking in patients with erectile dysfunction. Int J Impot Res 2005;17:527-534.
17. Boddi V, Corona G, Monami M, Fisher AD, Bandini E, Melani C, Balzi D, Sforza A, Patussi V, Forti G, Mannucci E, Maggi M. Priapus is happier with Venus than with Bacchus. J Sex Med 2010;7:2831-2841.
18. Corona G, Mannucci E, Petrone L, Balercia G, Fisher AD, Chiarini V, Forti G, Maggi M. ANDROTEST: A structured interview for the screening of hypogonadism in patients with sexual dysfunction. J Sex Med 2006;3:706-715.
19. Petrone L, Mannucci E, Corona G, Bartolini M, Forti G, Giommi R, Maggi M. Structured Interview on Erectile Dysfunction (SIEDY): A new, multidimensional instrument for quantification of pathogenetic issues on erectile dysfunction. Int J Impot Res 2003;15:210-220.
20. Corona G, Petrone L, Mannucci E, Jannini EA, Mansani R, Magini A, Giommi R, Forti G, Maggi M. Psycho-biological correlates of rapid ejaculation in patients attending an andrologic unit for sexual dysfunctions. Eur Urol 2004;46:615-622.
21. McGregor JC, Kim PW, Perencevich EN, Bradham DD, Furuno JP, Kaye KS, Fink JC, Langenberg P, Roghmann MC, Harris AD. Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol 2005;161:483-493.
22. Corona G, Rastrelli G, Monami M, Melani C, Balzi D, Sforza A, Forti G, Mannucci E, Maggi M. Body mass index regulates hypogonadism-associated CV risk: Results from a cohort of subjects with erectile dysfunction. J Sex Med 2011;8:2098-2105.
23. Corona G, Mannucci E, Lotti F, Fisher AD, Bandini E, Balercia G, Forti G, Maggi M. Pulse pressure, an index of arterial stiffness, is associated with androgen deficiency and impaired penile blood flow in men with ED. J Sex Med 2009;6:285-293.
24. Corona G, Monami M, Boddi V, Cameron-Smith M, Lotti F, de Vita G, Melani C, Balzi D, Sforza A, Forti G, Mannucci E, Maggi M. Male sexuality and cardiovascular risk. A cohort study in patients with erectile dysfunction. J Sex Med 2010;7:1918-1927.
25. Schiff JD, Li PS, Goldstein M. Correlation of ultrasonographic and orchidometer measurements of testis volume in adults. BJU Int 2004;93:1015-1017.
26. Fisher AD, Rastrelli G, Bandini E, Corona G, Balzi D, Melani C, Monami M, Matta V, Mannucci E, Maggi M. Metabolic and cardiovascular outcomes of fatherhood: Results from a cohort of study in subjects with sexual dysfunction. J Sex Med 2012;9:2785-2794.
27. Baird DT, Horton R, Langcope C, Tait JF. Steroid dynamics under steady state conditions. Recent Prog Horm Res 1969;25:611-664.
28. Trummer H, Habermann H, Haas J, Pummer K. The impact of cigarette smoking on human semen parameters and hormones. Hum Reprod 2002;17:1554-1559.
29. Svartberg J, Midtby M, Bønaa KH, Sundsfjord J, Joakimsen RM, Jorde R. The associations of age, lifestyle factors and chronic disease with testosterone in men: The Tromsø Study. Eur J Endocrinol 2003;149:145-152.
30. Laaksonen DE, Niskanen L, Punnonen K, Nyyssönen K, Tuomainen TP, Valkonen VP, Salonen JT. The metabolic syndrome and smoking in relation to hypogonadism in middle-aged men: A prospective cohort study. J Clin Endocrinol Metab 2005;90:712-719.
31. Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S, Vanderschueren D; European Male Aging Study Group. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: The European Male Aging Study. J Clin Endocrinol Metab 2008;93:2737-2745.
32. Mendelson JH, Sholar MB, Mutschler NH, Jaszyna-Gasior M, Goletiani NV, Siegel AJ, Mello NK. Effects of intravenous cocaine and cigarette smoking on luteinizing hormone, testosterone, and prolactin in men. J Pharmacol Exp Ther 2003;307:339-348.
33. Corona G, Rastrelli G, Ricca V, Maggi M. Testosterone deficiency in the aging male and its relationship with sexual dysfunction and cardiovascular diseases. Horm Mol Biol Clin Investig 2011;4:509-520.
34. Corona G, Rastrelli G, Vignozzi L, Mannucci E, Maggi M. Testosterone, cardiovascular disease and the metabolic syndrome. Best Pract Res Clin Endocrinol Metab 2011;25:337-353.
35. Corona G, Mannucci E, Forti G, Maggi M. Following the common association between testosterone deficiency and diabetes mellitus, can testosterone be regarded as a new therapy for diabetes? Int J Androl 2009;32:431-441.
36. Saad F, Aversa A, Isidori AM, Gooren LJ. Testosterone as potential effective therapy in treatment of obesity in men with testosterone deficiency: A review. Curr Diabetes Rev 2012;8:131-143.
37. MacDonald AA, Herbison GP, Showell M, Farquhar CM. The impact of body mass index on semen parameters and reproductive hormones in human males: A systematic review with meta-analysis. Hum Reprod Update 2010;16:293-311.
38. Pitteloud N, Hardin M, Dwyer AA, Valassi E, Yialamas M, Elahi D, Hayes FJ. Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. J Clin Endocrinol Metab 2005;90:2636-2641.
39. Corona G, Rastrelli G, Morelli A, Vignozzi L, Mannucci E, Maggi M. Hypogonadism and metabolic syndrome. J Endocrinol Invest 2011;34:557-567.
40. Traish AM, Guay A, Feeley R, Saad F. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. J Androl 2009;30:10-22.
41. Corona G, Forti G, Maggi M. Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome. Aging Male 2008;11:193-199.
42. Yeap BB, Hyde Z, Norman PE, Chubb SA, Golledge J. Associations of total testosterone, sex hormone-binding globulin, calculated free testosterone, and luteinizing hormone with prevalence of abdominal aortic aneurysm in older men. J Clin Endocrinol Metab 2010;95:1123-1130.
43. Hyde Z, Norman PE, Flicker L, Hankey GJ, McCaul KA, Almeida OP, Chubb SA, Yeap BB. Elevated LH predicts ischaemic heart disease events in older men: The Health in Men Study. Eur J Endocrinol 2011;164:569-577.
44. Hyde Z, Norman PE, Flicker L, Hankey GJ, Almeida OP, McCaul KA, Chubb SA, Yeap BB. Low free testosterone predicts mortality from cardiovascular disease but not other causes: The Health in Men Study. J Clin Endocrinol Metab 2012;97:179-189.
45. Corona G, Rastrelli G, Monami M, Guay A, Buvat J, Sforza A, Forti G, Mannucci E, Maggi M. Hypogonadism as a risk factor for cardiovascular mortality in men: A meta-analytic study. Eur J Endocrinol 2011;165:687-701.
46. Araujo AB, Dixon JM, Suarez EA, Murad MH, Guey LT, Wittert GA. Clinical review: Endogenous testosterone and mortality in men: A systematic review and meta-analysis. J Clin Endocrinol Metab 2011;96:3007-3019.
47. Ruige JB, Mahmoud AM, De Bacquer D, Kaufman JM. Endogenous testosterone and cardiovascular disease in healthy men: A meta-analysis. Heart 2011;97:870-875.
48. Dschietzig T, Bartsch C, Baumann G, Stangl K. Relaxin-A pleiotropic hormone and its emerging role for experimental and clinical therapeutics. Pharmacol Ther 2006;112:38-56.
49. Van den Berghe G. Novel insights into the neuroendocrinology of critical illness. Eur J Endocrinol 2000;143:1-13.
50. Vanhorebeek I, Van den Berghe G. The neuroendocrine response to critical illness is a dynamic process. Crit Care Clin 2006;22:1-15.
51. Corona G, Monami M, Boddi V, Cameron-Smith M, Fisher AD, de Vita GG, Melani C, Balzi D, Sforza A, Forti G, Mannucci E, Maggi M. Low testosterone is associated with increased risk of MACE lethality in subjects with erectile dysfunction. J Sex Med 2010;7:2557-2564.